REVERSIBLE SMALL-BOWEL OBSTRUCTION: WITHDRAWAL OF HYDROCHLOROTHIAZIDE-POTASSIUM CHLORIDE THERAPY.
D001581:Benzothiadiazines; D004232:Diuretics; D004358:Drug Therapy; D005853:Geriatrics; D006801:Humans; D006852:Hydrochlorothiazide; D007415:Intestinal Obstruction; D007421:Intestine, Small; D007422:Intestines; D011188:Potassium; D011189:Potassium Chloride; D049993:Sodium Chloride Symporter Inhibitors; D013607:Tablets; D013608:Tablets, Enteric-Coated; D014116:Toxicology
D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013607:Tablets; D013608:Tablets, Enteric-Coated; D006852:Hydrochlorothiazide; D011189:Potassium Chloride; D011188:Potassium
BENZOTHIADIAZINES; DIURETICS; DRUG THERAPY; GERIATRICS; HYDROCHLOROTHIAZIDE; INTESTINAL OBSTRUCTION; INTESTINE, SMALL; POTASSIUM; POTASSIUM CHLORIDE; TABLETS, ENTERIC-COATED; TOXICOLOGIC REPORT